Literature DB >> 2993665

Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein.

C M Edson, B A Hosler, R A Respess, D J Waters, D A Thorley-Lawson.   

Abstract

Cross-reactive monoclonal antibodies recognizing both herpes simplex virus (HSV) glycoprotein B and a major 63,000-dalton varicella-zoster virus (VZV) envelope glycoprotein were isolated and found to neutralize VZV infection in vitro. None of the other VZV glycoproteins was recognized by any polyclonal anti-HSV serum tested. These results demonstrate that HSV glycoprotein B and the 63,000-dalton VZV glycoprotein share antigenic epitopes and raise the possibility that these two proteins have a similar function in infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2993665      PMCID: PMC252547     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

3.  Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity.

Authors:  M Sarmiento; M Haffey; P G Spear
Journal:  J Virol       Date:  1979-03       Impact factor: 5.103

4.  Molecular genetics of herpes simplex virus. II. Mapping of the major viral glycoproteins and of the genetic loci specifying the social behavior of infected cells.

Authors:  W T Ruyechan; L S Morse; D M Knipe; B Roizman
Journal:  J Virol       Date:  1979-02       Impact factor: 5.103

5.  Antigenic relationship between varicella-herpes zoster and herpes simplex viruses studied by the gel precipitation reaction.

Authors:  J Trlifajová; J Sourek; M Ryba
Journal:  Acta Virol       Date:  1971-07       Impact factor: 1.162

6.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

7.  A rapid procedure for the enrichment of undenaturated, antigenically active herpes simplex virus glycoproteins.

Authors:  R A Respess; B A Pancake; C M Edson; P A Schaffer
Journal:  J Virol Methods       Date:  1984-02       Impact factor: 2.014

8.  Neutralizing antibody responses to varicella-zoster virus.

Authors:  N J Schmidt; E H Lennette
Journal:  Infect Immun       Date:  1975-09       Impact factor: 3.441

9.  Polypeptides of the Epstein-Barr virus membrane antigen complex.

Authors:  D A Thorley-Lawson; C M Edson
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

10.  Identification of a common antigen of herpes simplex virus bovine herpes mammillitis virus, and B virus.

Authors:  B Norrild; H Ludwig; R Rott
Journal:  J Virol       Date:  1978-06       Impact factor: 5.103

View more
  29 in total

1.  Specificity of skin test with varicella-zoster virus antigen in varicella-zoster and herpes simplex virus infections.

Authors:  K Baba; K Shiraki; T Kanesaki; K Yamanishi; P L Ogra; H Yabuuchi; M Takahashi
Journal:  J Clin Microbiol       Date:  1987-11       Impact factor: 5.948

2.  Epstein-Barr virus glycoprotein homologous to herpes simplex virus gB.

Authors:  M Gong; T Ooka; T Matsuo; E Kieff
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

3.  Compartment-specific immunolocalization of conserved epitopes of the glycoprotein gB of herpes simplex virus type 1 and bovine herpes virus type 2 in infected cells.

Authors:  S M Pietschmann; H R Gelderblom; G Pauli
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  Establishment by enzyme-linked immunosorbent assay of seronegative range for herpes simplex virus and cytomegalovirus antibodies and evaluation of heterologous responses to live varicella vaccine.

Authors:  A K Gong; S V Lipton; P A Brunell
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

5.  Low Varicella Zoster Virus Seroprevalence Among Young Children in the Democratic Republic of the Congo.

Authors:  Reena H Doshi; Vivian H Alfonso; Patrick Mukadi; Nicole A Hoff; Sue Gerber; Ado Bwaka; Stephen G Higgins; Cyrus Sinai; Brian Cowell; Guillaume Ngoie Mwamba; Emile Okitolonda; Jean-Jacques Muyembe-Tamfum; Anne W Rimoin
Journal:  Pediatr Infect Dis J       Date:  2018-02       Impact factor: 2.129

6.  Assembly and processing of the disulfide-linked varicella-zoster virus glycoprotein gpII(140).

Authors:  E A Montalvo; C Grose
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

7.  The pseudorabies virus gII gene is closely related to the gB glycoprotein gene of herpes simplex virus.

Authors:  A K Robbins; D J Dorney; M W Wathen; M E Whealy; C Gold; R J Watson; L E Holland; S D Weed; M Levine; J C Glorioso
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

8.  Immunological diagnosis in viral infections of the central nervous system: course of antibody titres against homo- and heterologous viruses.

Authors:  R H Dennin; E Herb
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

9.  Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.

Authors:  M Takayama
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

10.  Outbreak of chickenpox in a refugee camp of northern Thailand.

Authors:  Yusuke Shimakawa; Olivier Camélique; Koya Ariyoshi
Journal:  Confl Health       Date:  2010-02-22       Impact factor: 2.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.